Article
Downregulation of Gankyrin/PSMD10 affects cancer cell growth and proliferation in glioblastoma: <i>in vitro</i> and <i>in vivo</i> study
2024-12-05
Abstract excerpt
The oncoprotein Gankyrin/PSMD10 is upregulated in various cancers, including glioblastoma multiforme (GBM), the most difficult tumor to treat. The heterogeneity of this type of tumor requires a multi-targeted approach to overcome radio- and chemoresistance. Here we aim to investigate the effects of Gankyrin inhibition on glioma cell proliferation and its impact on sensitivity to chemotherapy both in vitro and in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 058a2d6f-ebd7-5b09-b4e7-cbe6645fae9c
- DOI
- 10.1101/2024.12.02.626412
